πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 416 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10018638

Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using E

The Board of Regents of the University of Texas System Β· Granted Tue Jul 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10010587

IL-2RΞ²-selective agonists in combination with an anti-CTLA-4 antibody or an anti-PD-1 anti

Nektar Therapeutics Β· Granted Tue Jul 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 28 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10004800

Antibody evolution immunogens

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer Β· Granted Tue Jun 26 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9975952

Antibody fragments, compositions and uses thereof

METIS PRECISION MEDICINE SB S.R.L. Β· Granted Tue May 22 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9968674

Methods and compositions comprising a combination of a VEGF Trap and an anti-CTLA-4 antibo

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue May 15 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 10 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9951141

Antibody-drug conjugates, their preparation and their therapeutic use

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9938339

Method for treating an eye disease or disorder by administering an antibody that binds ang

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9938350

Receptor tyrosine kinase-like orphan receptor 1 (ROR1) single chain Fv antibody fragment c

The Regents of the University of California Β· Granted Tue Apr 10 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 05 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9931414

Pyrrolobenzodiazepine-antibody conjugates

ADC THERAPEUTICS SA Β· Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9931415

Pyrrolobenzodiazepine-antibody conjugates

ADC THERAPEUTICS SA Β· Granted Tue Apr 03 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9926369

Methods for treating hepatocellular cancer by administering an anti-Ang-2 antibody

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue Mar 27 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 22 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9919056

Pyrrolobenzodiazepine-anti-CD22 antibody conjugates

ADC THERAPEUTICS SA Β· Granted Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9915668

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9856313

Epitope of RSV fusion protein and antibody recognizing the same

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jan 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 28 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9845357

Integrin Ξ±vΞ²8 neutralizing antibody

The Regents of the University of California Β· Granted Tue Dec 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9840558

Human antibody specific for interleukin-1alpha

XBIOTECH INC. Β· Granted Tue Dec 12 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 07 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9765147

Anti-CSFR1 antibody and anti PD-1 antibody combination therapy for cancer

Five Prime Therapeutics, Inc. Β· Granted Tue Sep 19 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 14 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9694071

Combination of anti-CD20 antibody and PI3 kinase selective inhibitor

TG Therapeutics, Inc. Β· Granted Tue Jul 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9676858

Human bispecific EGFRvIII antibody and CD3 engaging molecules

The United States of America as Represented by the Secretary Department of Health and Human Services (NIH) Β· Granted Tue Jun 13 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9650436

Antibody based reagents that specifically recognize toxic oligomeric forms of tau

ARIZONA BOARD OF REGENTS FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY Β· Granted Tue May 16 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9644018

Antibody modulators of APLNR

REGENERON PHARMACEUTICALS, INC. Β· Granted Tue May 09 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 04 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9636412

Conjugates of an anti-TNF-alpha antibody

Nektar Therapeutics Β· Granted Tue May 02 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9592290

Monoclonal antibody therapy for pancreas cancer

PRECISION BIOLOGICS, INC. Β· Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 9592238

Anti-ceramide monoclonal antibody 2A2

The Board of Regents of the University of Texas System Β· Granted Tue Mar 14 2017 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 09 2037 00:00:00 GMT+0000 (Coordinated Universal Time)

granted